chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 7.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Asthenia, Chest pain, Coma, Contusion, Fall
Clinical narrative: A report was received from a health care professional on 01/06/04, concerning a 7 year old female vaccinee who experienced nausea, surface chest pain, pallor, weakness, fainting and developed a bruise and knot on her head resulting from the fall, 5 minutes after receiving Fluvirin on 01/05/04. The vaccinee had received influenza vaccine (Fluzone) one month prior to vaccination with Fluvirin as the first dose. On 01/05/4, within 5 minutes of receiving Fluvirin the vaccinee fainted, fell to the floor and became unresponsive but was breathing. Within 30 seconds the vaccinee was alert and oriented but appeared pale and weak. Her heart rate ranged from 108-128 beats per minute. As a result of falling to the floor the vaccinee hit her head, causing swelling and a bruise to her head. The vaccinee was observed from 40 minutes, during which time she drank fluids and at crackers. The vaccinee was then taken to an emergency department where  she was observed for one hour and then sent home. In the emergency department the vaccinee complained of nausea and superficial chest discomfort. The vaccinee's mother was contacted on 1/6/04 and she indicated that the vaccinee was doing well. the vaccinee slept well and was eating well. The vaccinee still complained of nausea and superficial chest pain. There was insufficient information to determine the reporter's causality assessment. Update 1 03/30/04: A follow up report was received from a health care professional indicating that the vaccinee fainted on 01/05/04. The vaccinee was taken to a hospital emergency room on 01/05/04 and was discharged on the same day. The reporter indicated that according to the vaccinee's parent, the vaccinee had previous exposure to Fluvirin and did not experience any adverse symptoms previously. the vaccinee was vaccinated prior to receiving Fluvirin on 12/5/03.
Age: 7.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Heart rate increased, Nausea, Pallor, Syncope
Clinical narrative: A report was received from a health care professional on 01/06/04, concerning a 7 year old female vaccinee who experienced nausea, surface chest pain, pallor, weakness, fainting and developed a bruise and knot on her head resulting from the fall, 5 minutes after receiving Fluvirin on 01/05/04. The vaccinee had received influenza vaccine (Fluzone) one month prior to vaccination with Fluvirin as the first dose. On 01/05/4, within 5 minutes of receiving Fluvirin the vaccinee fainted, fell to the floor and became unresponsive but was breathing. Within 30 seconds the vaccinee was alert and oriented but appeared pale and weak. Her heart rate ranged from 108-128 beats per minute. As a result of falling to the floor the vaccinee hit her head, causing swelling and a bruise to her head. The vaccinee was observed from 40 minutes, during which time she drank fluids and at crackers. The vaccinee was then taken to an emergency department where  she was observed for one hour and then sent home. In the emergency department the vaccinee complained of nausea and superficial chest discomfort. The vaccinee's mother was contacted on 1/6/04 and she indicated that the vaccinee was doing well. the vaccinee slept well and was eating well. The vaccinee still complained of nausea and superficial chest pain. There was insufficient information to determine the reporter's causality assessment. Update 1 03/30/04: A follow up report was received from a health care professional indicating that the vaccinee fainted on 01/05/04. The vaccinee was taken to a hospital emergency room on 01/05/04 and was discharged on the same day. The reporter indicated that according to the vaccinee's parent, the vaccinee had previous exposure to Fluvirin and did not experience any adverse symptoms previously. the vaccinee was vaccinated prior to receiving Fluvirin on 12/5/03.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 05Jan03, concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 02Jan04. On 02Jan04 the vaccinee, who was less than 4 years of age, inadvertently received Fluvirin. The vaccinee had not experienced any signs or symptoms of an adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. No follow up pending. Cross reference with: PJP200400003.
Age: 0.93
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 5 January 2003, concerning a 3 year old male vaccinee who inadvertently received Fluvirin on 2 January 2004. On 2 January 2004 the vaccinee, who was less than 4 years of age, inadvertently received Fluvirin.  The vaccinee had not experienced any signs or symptoms of an adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. No follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 03 December 2003, concerning a 2 year old male vaccinee who was inadvertently administered Fluvirin on 02 December 2003. On 02 December 2003, the vaccinee inadvertently received Fluvirin.  No adverse effects were reported at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 0.97
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 03 December 2003, concerning an 11 month old female vaccinee who was inadvertently administered Fluvirin on 02 December 2003. On 02 December 2003, the vaccinee inadvertently received Fluvirin.  No adverse effects were reported at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 03 December 2003, concerning a 3 year old male vaccinee who was inadvertently administered Fluvirin on 02 December 2003. On 02 December 2003, the vaccinee inadvertently received Fluvirin.  No adverse effects were reported at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 03 December 2003, concerning an 8 month old female vaccinee who was inadvertently administered Fluvirin on 02 December 2003. On 02 December 2003, the vaccinee inadvertently received Fluvirin.  No adverse effects were reported at the time of report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Pruritus
Clinical narrative: A report was received from a healthcare professional on 15 October 2003 concerning a group of approximately 15 vaccinees who experienced injection site reaction, with redness, swelling and itching a few minutes after receiving Fluvirin on an unspecified date. On an unspecified date the vaccinees experienced injection site reactions with redness, swelling, and itching.  The vaccinees recovered on an unspecified date without treatment. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 22 December 2003. A follow up report was received from a healthcare professional concerning a 52 year old female vaccinee who experienced redness, swelling and moderate itching at the injection site on the same day as receiving Fluvirin on 10 October 2003. On 10 October 2003, the vaccinee experienced redness, swelling and moderate itching at the injection site after receiving Fluvirin 0.5ml.  The symptoms lasted for a duration of 2 hours, and had resolved at the time of follow up report. No follow up pending.
Age: 83.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Pruritus
Clinical narrative: A report was received from a healthcare professional on 15 October 2003 concerning a group of approximately 15 vaccinees who experienced injection site reaction, with redness, swelling and itching a few minutes after receiving Fluvirin on an unspecified date. On an unspecified date the vaccinees experienced injection site reactions with redness, swelling, and itching.  The vaccinees recovered on an unspecified date without treatment. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 22 December 2003. A follow up report was received from a healthcare professional concerning an 83 year old female vaccinee who experienced redness, swelling and moderate itching at the injection site on the same day as receiving Fluvirin on 06 October 2003. On 06 October 2003, the vaccinee experienced redness, swelling and moderate itching at the injection site after receiving Fluvirin 0.5ml.  The symptoms had resolved at the time of follow up report. No follow up pending.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site swelling, Pruritus
Clinical narrative: A report was received from a healthcare professional on 15 October 2003 concerning a group of approximately 15 vaccinees who experienced injection site reaction, with redness, swelling and itching a few minutes after receiving Fluvirin on an unspecified date. On an unspecified date the vaccinees experienced injection site reactions with redness, swelling, and itching.  The vaccinees recovered on an unspecified date without treatment. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 1, 22 December 2003. A follow up report was received from a healthcare professional concerning a 35 year old female vaccinee who experienced redness, swelling and severe itching at the injection site on the same day as receiving Fluvirin on 10 October 2003. On 10 October 2003, the vaccinee experienced redness, swelling and minor itching at the injection site after receiving Fluvirin 0.5ml.  The symptoms lasted for a duration of 30 minutes, and had resolved at the time of follow up report. No follow up pending.
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 30 October 2003, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, an unspecified number of vaccinees under 4 years of age inadvertently received Fluvirin.  No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 01 December 2003. Follow up information received from a healthcare professional indicated that a 2 and a half year old male vaccinee inadvertently received Fluvirin on 18 October 2003 and had not experienced any adverse event at the time of the report. No follow up pending, all information received.
Age: 1.5
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/2003, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that an 18 month old female vaccinee inadvertently received Fluvirin on 10/18/03 and had no experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400021, PJP200400022, PJP200400023 and PJP200400024.
Age: 3.5
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/2003, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/1/03: Follow up information received from a health care professional indicated that a 3 and a half year old male vaccinee inadvertently received Fluvirin on 10/18/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PHP200400014, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400021, PJP200400022, PJP200400023, PJP200400024.
Age: 1.1
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. N adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment.  Update 1, 12/1/03: Follow up information received from a health care professional indicated that a 14 month old male vaccinee inadvertently received Fluvirin on 10/18/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400021, PJP200400022, PJP200400023, PJP200400024.
Age: 0.75
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 9 month old female vaccinee inadvertently received Fluvirin on 10/23/03 and had not experienced any adverse event at the time of report. No follow up pending, all information received. Cross reference with: PJP2003000957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400018, PJP200400019, PJP200400021, PJP200400022, PJP200400023, PJP200400024.
Age: 0.58
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 7 month old male vaccinee inadvertently received Fluvirin on 10/23/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400019, PJP200400020, PJP200400021, PJP200400022, PJP200400023, PJP200400024.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 13 month old male vaccinee inadvertently received Fluvirin on 10/23/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400020, PJP2004200021, PJP200400022, PJP200400023, PJP200400024.
Age: 1.16
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 14 month old male vaccinee inadvertently received Fluvirin on 10/23/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400021, PJP200400022, PJP200400023, PJP200400024.
Age: 0.75
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/1/03: Follow up information received from a health care professional indicated that a 9 month old male vaccinee inadvertently received Fluvirin on 10/28/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014. PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400022, PJP200400023, PJP200400024.
Age: 1.6
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report.  There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 20 month old female vaccinee inadvertently received Fluvirin on 10/24/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received.  Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400021, PJP200400023, PJP200400024.
Age: 1.83
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 22 month old male vaccinee inadvertently received Fluvirin on 10/11/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference with: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP200400019, PJP200400020, PJP200400021, PJP200400022, PJP200400024.
Age: 1.33
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 10/30/03, concerning an unspecified number of vaccinees under 4 years of age who inadvertently received Fluvirin on an unspecified date. No adverse effects had occurred at the time of report. There was insufficient information to determine the reporter's causality assessment. Update 1, 12/01/03: Follow up information received from a health care professional indicated that a 16 month old female vaccinee inadvertently received Fluvirin on 10/11/03 and had not experienced any adverse event at the time of the report. No follow up pending, all information received. Cross reference: PJP200300957, PJP200400013, PJP200400014, PJP200400015, PJP200400016, PJP200400017, PJP200400018, PJP20040019, PJP200400020, PJP200400021, PJP200400022, PJP200400023.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Chest pain, Dyspnoea, Headache, Pain, Throat tightness
Clinical narrative: A report was received from a consumer on 06Jan04 concerning a 51 year old male vaccinee who experienced a severe headache approx 2 hours following vaccination, shortness of breath, heaviness in his chest and tightening of his throat approx 5 to 6 hours following administration of Fluvirin vaccine on an unspecified day in December 2003. On an unspecified day in Dec 2003 the vaccinee was administered Fluvirin and approx 2 hours later, the vaccinee experienced a severe headache and approx 5 to 6 hours later, the vaccinee experienced shortness of breath, heaviness in his chest and tightening of his throat. The vaccinee attended the ER and was treated with nitroglycerin and his pain subsequently resolved. The vaccinee stated that his BCG and blood tests were within normal limits. The attending physician did not provide a diagnosis for the vaccinees symptoms. The outcome was not reported. The vaccinee was also evaluated by his primary care physician who stated that she did not think the pt's symptoms were related to the vaccine. Follow up pending.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 24Oct03, concerning three female vaccinees of unk age who were inadvertently administered last years vaccine (2002-2003) on an unk date. On an unk date three female vaccinees were inadvertently administered last years vaccine (2002-2003). No adverse reactions had occurred at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1:10Dec03, Follow up report was received from a health care professional on 10Dec03 which indicated that a 50 year old female vaccinee inadvertently received 1ml of expired Fluvirin on 23Oct03. No adverse events were reported to date. Follow up pending. Cross referenced to PJP200300917 and PJP2003200400033.
Sex: U
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 06Jan04 concerning an adult vaccinee of unknown gender who inadvertently received two 0.5ml doses of Fluvirin vaccine, one dose on 23Dec03 and a second dose on 06Jan04. The vaccinee was inadvertently administered two doses of Fluvirin two weeks apart. The nurse who administered the vaccine was confused due to the 0.25ml marking on the Fluvirin pre-filled syringes and did not realize until after the second dose was administered that each pre-filled syringe contained 0.5ml. The vaccinee did not experience any adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Accidental overdose, Medication error, Vaccination complication
Clinical narrative: Administration of expired product (Medication error, medication error)(Med error) - not reported Vaccinee received 1ml of vaccine (Accidental overdose, Accidental overdose)(Overdose accid) - not reported A report was received from a health care professional on 24 October 2003 concerning three female vaccinees of unknown age who were inadvertently administered last years' vaccine (2002-2003) on an unknown date. On an unknown date three female vaccinees were inadvertently administered last years' vaccine (2002-2003). No adverse reactions had occurred at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1: 10 December 2003 Follow-up report was received from a health care professional on 10 December 2003 which indicated that a 35 year old female vaccinee inadvertently received 1ml of expired Fluvirin on 23 October 2003. No adverse events were reported to date. Follow-up pending. Cross reference to PJP-2003-00917 and PJP-2003-00028.
Age: 22.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Headache, Medication error, Myalgia, Pyrexia
Clinical narrative: Serum sickness (Serum sickness, Serum Sickness)(Serum Sick) - recovered/resolved Headache (Headache, Headache) - recovered/resolved Morbilliform Rash (Rash, Rash) - recovered/resolved Fever (Fever, Fever) - recovered/resolved Chills (Chills, Chills) - recovered/resolved Myalgia (Myalgia, Myalgia) - recovered/resolved Administration by unlicensed route (Medication error, Medication error)(Med Error) - not reported Administration of sub-optimal dose (Medication error, Medication error)(Med Error) - not reported A report was received from a health care professional on 07 January 2004 concerning a 22 year old male vaccinee who experienced serum sickness after inadvertently receiving 0.1ml of Fluvirin intradermally on 19 December 2003. On 19 December 2003 a vaccinee received 0.1ml of Fluvirin intradermally and approximately 24 December 2003 the vaccinee experienced a headache. On approximately 26 December 2003 the vaccinee experienced a morbilliform rash, fever, chills and myalgia which resolved on approximately 01 January 2004. The vacinee was diagnosed with serum sickness. On 30 December 2003 approximately, the vaccinee was treated with prednisone for two days which was then tapered  off over the next several days. The serum sickness resolved on an unspecified date. There was insufficient information to determine the reporter's causality assessment. Follow-up pending.
Age: 22.0
Sex: M
Vaccine: FLU3
Symptoms: Rash morbilliform, Serum sickness
Clinical narrative: Serum sickness (Serum sickness, Serum Sickness)(Serum Sick) - recovered/resolved Headache (Headache, Headache) - recovered/resolved Morbilliform Rash (Rash, Rash) - recovered/resolved Fever (Fever, Fever) - recovered/resolved Chills (Chills, Chills) - recovered/resolved Myalgia (Myalgia, Myalgia) - recovered/resolved Administration by unlicensed route (Medication error, Medication error)(Med Error) - not reported Administration of sub-optimal dose (Medication error, Medication error)(Med Error) - not reported A report was received from a health care professional on 07 January 2004 concerning a 22 year old male vaccinee who experienced serum sickness after inadvertently receiving 0.1ml of Fluvirin intradermally on 19 December 2003. On 19 December 2003 a vaccinee received 0.1ml of Fluvirin intradermally and approximately 24 December 2003 the vaccinee experienced a headache. On approximately 26 December 2003 the vaccinee experienced a morbilliform rash, fever, chills and myalgia which resolved on approximately 01 January 2004. The vacinee was diagnosed with serum sickness. On 30 December 2003 approximately, the vaccinee was treated with prednisone for two days which was then tapered  off over the next several days. The serum sickness resolved on an unspecified date. There was insufficient information to determine the reporter's causality assessment. Follow-up pending.
Age: 1.51
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: Administration to a child under 4 years of age (Medication Error, Medication Error)(Med Error) - not reported. A report was received from a health care professional on 25 November 2003, concerning an 18 month old female vaccinee who advertently received Fluvirin on 07 November 2003.  On 07 November 2003 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow-up pending, all information received.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: Administration to a child under 4 years of age (Medication Error, Medication Error) (Med Error) - not reported  A report was received from a health care professional on 25 November 2003, concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 20 November 2003. On 20 November 2003 the vacinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow-up pending, all information received.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: Administration to a child under 4 years of age (Medication Error, Medication Error) (Med Error) - not reported  A report was received from a health care professional on 25 November 2003, concerning a 2 year old female vaccinee who advertently received Fluvirin on 21 November 2003. On 21 November 2003 the vacinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow-up pending, all information received.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 2 year old male vaccine who inadvertently received Fluvirin on 14 November 2003.  On 14 November 2003 the vaccine inadvertently received 0.25ml of Fluvirin.  At the time of the report no adverse events had been reported.  There was insufficient information to determine the reporter's causality assessment.  Update 1, 11 March 2004:  Further information received from a health care professional indicated that the vaccine did not experience any adverse reaction at the time of the report.  No follow-up pending, all information received.
Age: 0.61
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 25Nov03, concerning a 7 month old male vaccinee who inadvertently received Fluvirin on 20Nov03. On 20Nov03 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporters causality assessment. Update 1, 11March04: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400036, PJP200400039, PJP200400038, PJP200400037.
Age: 1.34
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 25Nov03, concerning a 16 month old female vaccinee who inadvertently received Fluvirin on 21Nov03. On 21Nov03 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporters causality assessment. Update 1, 11Mar04:Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400040, PJP200400039, PJP200400038,  PJP200400037.
Age: 1.75
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 25Nov03, concerning a 21 month old female vaccinee who inadvertently received Fluvirin on 19Nov03. On 19Nov03 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporters causality assessment. Update 1, 11March04: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037,PJP200400036.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 25Nov03, concerning a 27 month old female vaccinee who inadvertently received Fluvirin on 18Nov03. On 18Nov03 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporters causality assessment. Update 1, 11March04: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 31 month old female vaccinee who inadvertently received Fluvirin on 18 November 2003. On 18 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. AT the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP100700037, PJP200400036.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 11 month old male vaccinee who inadvertently received Fluvirin on 14 November 2003. On 14 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 0.66
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 7 month old male vaccinee who inadvertently received Fluvirin on 20 November 2003. On 20 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 0.65
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 7 month old male vaccinee who inadvertently received Fluvirin on 07 November 2003. On 07 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 1.79
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 21 month old female vaccinee who inadvertently received Fluvirin on 18 November 2003. On 18 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 24 November 2003. On 24 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 05 November 2003. On 05 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 30 month old female vaccinee who inadvertently received Fluvirin on 21 November 2003. On 21 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 07 November 2003. On 07 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 25 November 2003, concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 12 November 2003. On 12 November 2003 the vaccinee inadvertently received 0.25 ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400041, PJP200400040, PJP200400039, PJP200400038, PJP200400037, PJP200400036.
Age: 1.46
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 09Jan04 concerning a 16 month old male vaccinee who inadvertently received Fluvirin on 09Jan04. On 09Jan04 the vaccinee inadvertently received Fluvirin. The vaccinee did not exhibit any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1, 08Mar04. Follow up information received from a health care professional indicated that the vaccinee was 17 months old at the time of vaccination. No adverse events were reported to date. No follow up pending, all information received.
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Headache, Myalgia, Night sweats, Pyrexia
Clinical narrative: A report was received from a health care professional on 09Oct03 concerning two vaccinees of unk demography who experienced fever, night sweats, stiff joints and headache on 07Oct03 after receiving Fluvirin vaccine on 07Oct03. On 07Oct03, two vaccines received Fluvirin and later that evening they both experienced fever of 101-102 degrees F, night sweats, stiff joints and headache. The vaccinees symptoms improved on 09Oct03. There was insufficient information to determine the reporter's causality assessment. No follow up pending as the reporter will not collect any further information. Update 1, 17Dec03. A follow up report was received from a health care professional concerning a male vaccinee, of unspecified age who experienced fever, night sweats, stiff joints, headache and achiness all over on 07Oct03 after receiving Fluvirin vaccine on the same day. On 07Oct03 the vaccinee experienced fever, night sweats, stiff joints, headache and achiness all over following Fluvirin vaccination. No follow up pending as the reporter will not collect any further information. Cross Reference with PJP200300788.
Age: 1.58
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a consumer on 12Jan04 concerning a 19 month old male vaccinee who received Fluvirin on 11Dec03. On 11Dec03, the vaccinee received 0.5ml Fluvirin. The vaccinee did not complain of any adverse reaction. Follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Unevaluable event
Clinical narrative: A report was received from a health care professional on 12Nov03, concerning an unspecified number of vaccinees under 4 years who have inadvertently received Fluvirin on unspecified date. On an unspecified date vaccinees under 4 years inadvertently received Fluvirin IM. The vaccinee did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporters causality assessment. Update 1, 07Jan04. A follow up report was received from a health care professional concerning a 2 year old male vaccine who inadvertently received Fluvirin on 07Nov03. On 07Nov03, the vaccinee inadvertently received Fluvirin. The vaccinee did not experienced any adverse symptoms at the time of reporting. No follow up pending, all information received. Multiple report cross reference with: PJP200301062, PJP200400064, PJP200400065, PJP200400066, PJP200400067, PJP200400068, PJP200069, PJP200400070, PJP200400071, PJP200400072, PJP200400073, PJP200400074, PJP20040075, PJP200400076, PJP200400077, PJP200400078, PJP200400079.